SRPT logo

Sarepta Therapeutics (SRPT) Cash from operations

annual CFO:

-$205.79M+$295.21M(+58.92%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual cash flow from operations is -$205.79 million, with the most recent change of +$295.21 million (+58.92%) on December 31, 2024.
  • During the last 3 years, SRPT annual CFO has risen by +$237.38 million (+53.56%).
  • SRPT annual CFO is now -291.49% below its all-time high of $107.47 million, reached on December 31, 2020.

Performance

SRPT Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTcash flow metrics

quarterly CFO:

-$583.44M-$675.48M(-733.85%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly cash flow from operations is -$583.44 million, with the most recent change of -$675.48 million (-733.85%) on March 1, 2025.
  • Over the past year, SRPT quarterly CFO has dropped by -$341.36 million (-141.01%).
  • SRPT quarterly CFO is now -192.94% below its all-time high of $627.79 million, reached on March 31, 2020.

Performance

SRPT quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTcash flow metrics

TTM CFO:

-$547.15M-$341.36M(-165.88%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT TTM cash flow from operations is -$547.15 million, with the most recent change of -$341.36 million (-165.88%) on March 1, 2025.
  • Over the past year, SRPT TTM CFO has dropped by -$13.47 million (-2.52%).
  • SRPT TTM CFO is now -272.30% below its all-time high of $317.56 million, reached on March 31, 2020.

Performance

SRPT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SRPT Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+58.9%-141.0%-2.5%
3 y3 years+53.6%-476.7%-50.3%
5 y5 years+54.9%-192.9%-272.3%

SRPT Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+58.9%-733.9%at low-165.9%at low
5 y5-year-291.5%+58.9%-192.9%at low-272.3%+22.1%
alltimeall time-291.5%+58.9%-192.9%at low-272.3%+22.1%

SRPT Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$583.44M(-733.9%)
-$547.15M(+165.9%)
Dec 2024
-$205.79M(-58.9%)
$92.05M(-230.2%)
-$205.79M(-41.6%)
Sep 2024
-
-$70.70M(-573.2%)
-$352.49M(-11.1%)
Jun 2024
-
$14.94M(-106.2%)
-$396.50M(-25.7%)
Mar 2024
-
-$242.08M(+342.9%)
-$533.67M(+6.5%)
Dec 2023
-$500.99M(+54.0%)
-$54.66M(-52.4%)
-$500.99M(-7.0%)
Sep 2023
-
-$114.71M(-6.2%)
-$538.73M(+10.2%)
Jun 2023
-
-$122.23M(-41.6%)
-$488.99M(+12.8%)
Mar 2023
-
-$209.40M(+126.6%)
-$433.57M(+33.3%)
Dec 2022
-$325.35M(-26.6%)
-$92.39M(+42.2%)
-$325.35M(+24.0%)
Sep 2022
-
-$64.96M(-2.8%)
-$262.28M(-18.5%)
Jun 2022
-
-$66.81M(-34.0%)
-$321.64M(-11.6%)
Mar 2022
-
-$101.17M(+245.0%)
-$363.98M(-17.9%)
Dec 2021
-$443.17M(-512.4%)
-$29.33M(-76.4%)
-$443.17M(-24.7%)
Sep 2021
-
-$124.33M(+13.9%)
-$588.38M(-16.2%)
Jun 2021
-
-$109.15M(-39.5%)
-$702.24M(+0.2%)
Mar 2021
-
-$180.37M(+3.3%)
-$700.70M(-752.0%)
Dec 2020
$107.47M(-123.5%)
-$174.53M(-26.7%)
$107.47M(-9.1%)
Sep 2020
-
-$238.19M(+121.4%)
$118.21M(-59.1%)
Jun 2020
-
-$107.60M(-117.1%)
$288.96M(-9.0%)
Mar 2020
-
$627.79M(-483.3%)
$317.56M(-169.6%)
Dec 2019
-$456.46M(+17.4%)
-$163.79M(+142.9%)
-$456.46M(+10.0%)
Sep 2019
-
-$67.43M(-14.6%)
-$415.09M(-10.0%)
Jun 2019
-
-$79.00M(-46.0%)
-$460.98M(-7.7%)
Mar 2019
-
-$146.23M(+19.5%)
-$499.23M(+28.4%)
Dec 2018
-$388.66M(+67.5%)
-$122.42M(+8.0%)
-$388.66M(+30.7%)
Sep 2018
-
-$113.32M(-3.4%)
-$297.30M(+22.9%)
Jun 2018
-
-$117.25M(+228.7%)
-$241.88M(+15.3%)
Mar 2018
-
-$35.67M(+14.8%)
-$209.78M(-9.6%)
Dec 2017
-$232.00M(-5.6%)
-$31.06M(-46.4%)
-$232.00M(-17.8%)
Sep 2017
-
-$57.90M(-32.0%)
-$282.17M(-1.0%)
Jun 2017
-
-$85.15M(+47.1%)
-$284.88M(+17.2%)
Mar 2017
-
-$57.89M(-28.7%)
-$243.02M(-1.1%)
Dec 2016
-$245.82M(+64.5%)
-$81.23M(+34.0%)
-$245.82M(+25.5%)
Sep 2016
-
-$60.62M(+40.0%)
-$195.86M(+7.9%)
Jun 2016
-
-$43.28M(-28.7%)
-$181.56M(+8.8%)
Mar 2016
-
-$60.69M(+94.1%)
-$166.81M(+11.6%)
Dec 2015
-$149.47M(+16.3%)
-$31.27M(-32.5%)
-$149.47M(+4.1%)
Sep 2015
-
-$46.31M(+62.3%)
-$143.64M(+8.3%)
Jun 2015
-
-$28.53M(-34.2%)
-$132.65M(-7.6%)
Mar 2015
-
-$43.35M(+70.3%)
-$143.62M(+11.7%)
Dec 2014
-$128.54M(+98.7%)
-$25.45M(-27.9%)
-$128.54M(+6.3%)
Sep 2014
-
-$35.32M(-10.6%)
-$120.91M(+14.6%)
Jun 2014
-
-$39.50M(+39.8%)
-$105.47M(+35.3%)
Mar 2014
-
-$28.27M(+58.6%)
-$77.97M(+20.5%)
Dec 2013
-$64.69M(+117.9%)
-$17.82M(-10.3%)
-$64.69M(+19.7%)
Sep 2013
-
-$19.88M(+65.6%)
-$54.03M(+28.8%)
Jun 2013
-
-$12.00M(-19.9%)
-$41.96M(+17.7%)
Mar 2013
-
-$14.99M(+109.5%)
-$35.64M(+20.0%)
Dec 2012
-$29.69M(+25.4%)
-$7.16M(-8.3%)
-$29.69M(+5.4%)
Sep 2012
-
-$7.80M(+37.4%)
-$28.18M(+1.0%)
Jun 2012
-
-$5.68M(-37.2%)
-$27.90M(+23.1%)
Mar 2012
-
-$9.05M(+60.2%)
-$22.66M(-4.3%)
Dec 2011
-$23.68M(+55.7%)
-$5.65M(-24.9%)
-$23.68M(+18.9%)
Sep 2011
-
-$7.52M(+1602.0%)
-$19.92M(+31.3%)
Jun 2011
-
-$442.00K(-95.6%)
-$15.17M(-20.0%)
Mar 2011
-
-$10.07M(+433.2%)
-$18.96M(+24.7%)
DateAnnualQuarterlyTTM
Dec 2010
-$15.21M(+72.8%)
-$1.89M(-31.9%)
-$15.21M(+5.8%)
Sep 2010
-
-$2.77M(-34.5%)
-$14.38M(+7.8%)
Jun 2010
-
-$4.24M(-32.9%)
-$13.34M(-1.1%)
Mar 2010
-
-$6.31M(+497.2%)
-$13.50M(+53.4%)
Dec 2009
-$8.80M(-28.7%)
-$1.06M(-39.2%)
-$8.80M(-13.9%)
Sep 2009
-
-$1.74M(-60.4%)
-$10.22M(-19.6%)
Jun 2009
-
-$4.39M(+171.8%)
-$12.71M(+33.4%)
Mar 2009
-
-$1.61M(-34.8%)
-$9.53M(-22.8%)
Dec 2008
-$12.34M(-50.0%)
-$2.48M(-41.4%)
-$12.34M(-28.2%)
Sep 2008
-
-$4.23M(+249.1%)
-$17.19M(-2.2%)
Jun 2008
-
-$1.21M(-72.6%)
-$17.58M(-25.5%)
Mar 2008
-
-$4.43M(-39.6%)
-$23.61M(-4.3%)
Dec 2007
-$24.68M(+19.7%)
-$7.33M(+58.6%)
-$24.68M(+9.7%)
Sep 2007
-
-$4.62M(-36.2%)
-$22.49M(-4.1%)
Jun 2007
-
-$7.24M(+31.7%)
-$23.45M(+12.6%)
Mar 2007
-
-$5.49M(+6.8%)
-$20.82M(+1.0%)
Dec 2006
-$20.61M(+40.5%)
-$5.15M(-7.6%)
-$20.61M(+1.9%)
Sep 2006
-
-$5.57M(+20.9%)
-$20.24M(+30.6%)
Jun 2006
-
-$4.61M(-12.8%)
-$15.50M(-0.5%)
Mar 2006
-
-$5.29M(+10.9%)
-$15.58M(+6.2%)
Dec 2005
-$14.67M(-38.3%)
-$4.77M(+475.4%)
-$14.67M(+10.0%)
Sep 2005
-
-$828.90K(-82.3%)
-$13.33M(-26.5%)
Jun 2005
-
-$4.69M(+7.1%)
-$18.15M(-11.2%)
Mar 2005
-
-$4.38M(+27.6%)
-$20.43M(-14.1%)
Dec 2004
-$23.78M(+36.0%)
-$3.43M(-39.2%)
-$23.78M(-4.8%)
Sep 2004
-
-$5.65M(-19.0%)
-$24.98M(+9.6%)
Jun 2004
-
-$6.97M(-9.8%)
-$22.79M(+20.8%)
Mar 2004
-
-$7.73M(+67.0%)
-$18.86M(+7.9%)
Dec 2003
-$17.48M(-13.7%)
-$4.63M(+33.8%)
-$17.48M(+6.1%)
Sep 2003
-
-$3.46M(+13.6%)
-$16.47M(-2.8%)
Jun 2003
-
-$3.04M(-52.0%)
-$16.94M(-23.5%)
Mar 2003
-
-$6.35M(+75.4%)
-$22.14M(+9.3%)
Dec 2002
-$20.26M(+58.0%)
-$3.62M(-7.8%)
-$20.26M(-0.2%)
Sep 2002
-
-$3.93M(-52.3%)
-$20.31M(+5.3%)
Jun 2002
-
-$8.24M(+84.2%)
-$19.28M(+32.9%)
Mar 2002
-
-$4.47M(+22.1%)
-$14.51M(+13.1%)
Dec 2001
-$12.82M(+40.5%)
-$3.66M(+26.1%)
-$12.82M(+2.8%)
Sep 2001
-
-$2.91M(-16.1%)
-$12.48M(+10.7%)
Jun 2001
-
-$3.46M(+24.1%)
-$11.27M(+7.3%)
Mar 2001
-
-$2.79M(-15.9%)
-$10.50M(+15.0%)
Dec 2000
-$9.13M(+20.1%)
-$3.32M(+95.2%)
-$9.13M(+18.4%)
Sep 2000
-
-$1.70M(-36.9%)
-$7.71M(-2.5%)
Jun 2000
-
-$2.69M(+90.1%)
-$7.91M(+6.7%)
Mar 2000
-
-$1.42M(-25.4%)
-$7.42M(-2.4%)
Dec 1999
-$7.60M(+13.4%)
-$1.90M(0.0%)
-$7.60M(-3.8%)
Sep 1999
-
-$1.90M(-13.6%)
-$7.90M(+25.4%)
Jun 1999
-
-$2.20M(+37.5%)
-$6.30M(-1.6%)
Mar 1999
-
-$1.60M(-27.3%)
-$6.40M(-4.5%)
Dec 1998
-$6.70M(+123.3%)
-$2.20M(+633.3%)
-$6.70M(+19.6%)
Sep 1998
-
-$300.00K(-87.0%)
-$5.60M(-11.1%)
Jun 1998
-
-$2.30M(+21.1%)
-$6.30M(+40.0%)
Mar 1998
-
-$1.90M(+72.7%)
-$4.50M(+50.0%)
Dec 1997
-$3.00M(+87.5%)
-$1.10M(+10.0%)
-$3.00M(+57.9%)
Sep 1997
-
-$1.00M(+100.0%)
-$1.90M(+111.1%)
Jun 1997
-
-$500.00K(+25.0%)
-$900.00K(+125.0%)
Mar 1997
-
-$400.00K
-$400.00K
Dec 1996
-$1.60M
-
-

FAQ

  • What is Sarepta Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual CFO year-on-year change?
  • What is Sarepta Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly CFO year-on-year change?
  • What is Sarepta Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Sarepta Therapeutics?
  • What is Sarepta Therapeutics TTM CFO year-on-year change?

What is Sarepta Therapeutics annual cash flow from operations?

The current annual CFO of SRPT is -$205.79M

What is the all time high annual CFO for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual cash flow from operations is $107.47M

What is Sarepta Therapeutics annual CFO year-on-year change?

Over the past year, SRPT annual cash flow from operations has changed by +$295.21M (+58.92%)

What is Sarepta Therapeutics quarterly cash flow from operations?

The current quarterly CFO of SRPT is -$583.44M

What is the all time high quarterly CFO for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly cash flow from operations is $627.79M

What is Sarepta Therapeutics quarterly CFO year-on-year change?

Over the past year, SRPT quarterly cash flow from operations has changed by -$341.36M (-141.01%)

What is Sarepta Therapeutics TTM cash flow from operations?

The current TTM CFO of SRPT is -$547.15M

What is the all time high TTM CFO for Sarepta Therapeutics?

Sarepta Therapeutics all-time high TTM cash flow from operations is $317.56M

What is Sarepta Therapeutics TTM CFO year-on-year change?

Over the past year, SRPT TTM cash flow from operations has changed by -$13.47M (-2.52%)
On this page